7th Eurasian Hematology Oncology Summit

 

7th Eurasian Hematology Oncology Summit
R

Management of Ph+ Leukemia During COVID-19 Pandemic: Is Induction / Consolidation Dasatinib + Blinatumomab the Optimal Solution?

By 7th Eurasian Hematology Oncology Summit FEATURING Robin Foa
By 7th Eurasian Hematology Oncology Summit FEATURING Robin Foa
0 views
December 15, 2020
Comments 0
Login to view comments. Click here to Login

Featured Video

16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison

Featured Video

24:35
Indy Hematology Review

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Feat. A. Tefferi
COVID-19
19:08
7th Eurasian Hematology Oncology Summit

Management of Ph+ Leukemia During COVID-19 Pandemic: Is Induction / …

Feat. R. Foa
17:27
7th Eurasian Hematology Oncology Summit

How SARS-CoV-2 Affects Cancer Patients: Epidemiology, Behavior, Symp…

Feat. R. Chemaly
16:36
7th Eurasian Hematology Oncology Summit

CLL Management During the COVID-19 Pandemic: New Strategies and Cons…

Feat. R. Foa